You have 10 free articles left this month. Get your freeBasic subscription now and gain instant access to more.

CEO buys 2,926 shares in Bulgarian drug maker Sopharma

Author Mario Tanev
CEO buys 2,926 shares in Bulgarian drug maker Sopharma Sopharma/ All rights reserved

SOFIA (Bulgaria), September 17 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Tuesday that its CEO Ognyan Donev has acquired 2,926 shares in the company at a weighted average price per share of 3.4061 levs ($1.92/1.74 euro).

Donev acquired the shares through deals on the Bulgarian Stock Exchange on September 16, Sopharma said in a bourse filing.

Donev has been actively acquiring small packages of Sopharma shares since the start of September. Since then, Donev has made only one sale, of 3,620 shares.

At the end of June, Donev held a stake of below 5% in Sopharma, according to the company's most recent interim financial statement.

However, Ognyan Donev is indirectly the biggest shareholder in Sopharma, as he controls a 25.39% stake through his company Donev Investments Holding. Donev is also a major shareholder in Sopharma's second biggest shareholder - Telecomplect Invest. Telecomplect Invest controls 20.68% interest in Sopharma.

As at 13:05 CET on Tuesday, Sopharma shares traded 0.59% higher at 3.42 levs on the Bulgarian Stock Exchange.

(1 euro = 1.95583 levs)

Compare